Efficacy and safety of azvudine in symptomatic adult COVID-19 participants who are at increased risk of progressing to critical illness: a study protocol for a multicentre randomized double-blind placebo-controlled phase III trial.
Xinlun TianYan XuLuo WangChongya DongXiaoyan YanJunping FanHuaiya XieHong ZhangJinglan WangYongjian LiuYaqi WangSiqi PanAohua WuXueqi LiuChen YaoMengzhao WangPublished in: Trials (2024)
ClinicalTrials.gov NCT05689034. Registered on 18 January 2023.